Operator
Good afternoon and welcome to the Agile Therapeutics first-quarter 2021 financial results conference call. Please note today's event is being recorded. I would like to turn the conference over to Matt Riley, head of investor relations.
Matt Riley --
Head of Investor Relations
Hello, everyone, and welcome to today's conference call to discuss our first-quarter 2021 financial results and corporate update. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future, management's expectations for our future financial and operational performance, our business strategy, our assessment of the combined hormonal contraceptive market, and the potential market share for Twirla, among other statements regarding our plans prospects and expectations. Such statements represent our judgment as of today, are not promises or guarantees, and may involve risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements. Please refer to our filings with the SEC which are available through the Investor Relations section of our website for information concerning risk factors that may affect the company.